Novel actionable ROS1::GIT2 fusion in non-Langerhans cell histiocytosis with central nervous system involvement

被引:0
|
作者
Bedics, Gabor [1 ,2 ]
Csoka, Monika [3 ]
Reiniger, Lilla [1 ]
Varga, Edit [3 ]
Liptai, Zoltan [3 ]
Papp, Gergo [1 ]
Beko, Anna [1 ,2 ]
Cervi, Catherine [3 ]
Bodor, Csaba [1 ,2 ]
Scheich, Balint [1 ]
机构
[1] Semmelweis Univ, Dept Pathol & Expt Canc Res, Ulloi Ut 26, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Dept Pathol & Expt Canc Res, HCEMM SU Mol Oncohematol Res Grp, Ulloi Ut 26, H-1085 Budapest, Hungary
[3] Semmelweis Univ, Dept Pediat 2, Tuzolto U 7-9, H-1094 Budapest, Hungary
基金
欧盟地平线“2020”;
关键词
D O I
10.1007/s00401-022-02520-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:153 / 156
页数:4
相关论文
共 38 条
  • [1] Novel actionable ROS1::GIT2 fusion in non-Langerhans cell histiocytosis with central nervous system involvement
    Gábor Bedics
    Monika Csóka
    Lilla Reiniger
    Edit Varga
    Zoltán Liptai
    Gergő Papp
    Anna Bekő
    Catherine Cervi
    Csaba Bödör
    Bálint Scheich
    Acta Neuropathologica, 2023, 145 : 153 - 156
  • [2] Langerhans cell histiocytosis in the central nervous system:: meningeal involvement
    Alegre, MLS
    Almazán, LM
    Alcalá, AL
    Villayandre, JMA
    López, GD
    REVISTA CLINICA ESPANOLA, 1999, 199 (08): : 520 - 522
  • [3] CENTRAL NERVOUS SYSTEM LESIONS COMPATIBLE WITH NEURODEGENERATIVE INVOLVEMENT IN LANGERHANS CELL HISTIOCYTOSIS
    Monges, Soledad
    Constanza Pasteris, C.
    Vaiani, Elisa
    Rugilo, Carlos
    Lopez, Viviana
    Braier, Jorge
    PEDIATRIC BLOOD & CANCER, 2014, 61 (11) : 2136 - 2137
  • [4] Visual loss with Langerhans cell histiocytosis: Multifocal central nervous system involvement
    Job, OM
    Schatz, NJ
    Glaser, JS
    JOURNAL OF NEURO-OPHTHALMOLOGY, 1999, 19 (01) : 49 - 53
  • [5] Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab
    Chohan, Gurjit
    Barnett, Yael
    Gibson, John
    Reddel, Stephen W. R.
    Barnett, Michael H.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (05): : 574 - 578
  • [6] Langerhans cell histiocytosis: Central nervous system involvement treated successfully with 2-chlorodeoxyadenosine
    Watts, J
    Files, B
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2001, 18 (03) : 199 - 204
  • [7] Non-Langerhans Cell Histiocytosis: Comprehensive Genomic Profiling Reveals Novel and Potentially Actionable FLT3 Gene Fusions
    Williams, Erik
    Mata, Douglas
    Pavlick, Dean
    Crowley, Helena
    Tse, Julie
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 366 - 367
  • [8] Non-Langerhans Cell Histiocytosis: Comprehensive Genomic Profiling Reveals Novel and Potentially Actionable FLT3 Gene Fusions
    Williams, Erik
    Mata, Douglas
    Pavlick, Dean
    Crowley, Helena
    Tse, Julie
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 366 - 367
  • [9] A novel GAB2::BRAF fusion in cutaneous non-Langerhans-cell histiocytosis with systemic involvement
    Wu, Bicong
    Konnick, Eric Q.
    Kimble, Erik L.
    Hendrie, Paul C.
    Shinohara, Michi M.
    Moshiri, Ata S.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2022, 49 (08) : 727 - 730
  • [10] Central Nervous System Involvement in Langerhans Cell Histiocytosis: The Importance of Long Term Follow-Up
    Perry, V. Hugh
    PEDIATRIC BLOOD & CANCER, 2011, 56 (02) : 175 - 176